Immunotherapeutic Value of MAP1LC3C and Its Candidate FDA-Approved Drugs Identified by Pan-Cancer Analysis, Virtual Screening and Sensitivity Analysis

• Päätekijät: Xudong Zhang (Tekijä), Kunhang Li (Tekijä), Shiyu Zhong (Tekijä), Shengyu Liu (Tekijä), Tao Liu (Tekijä), Lishuai Li (Tekijä), Shuo Han (Tekijä), Qingqing Zhai (Tekijä), Nan Bao (Tekijä), Xin Shi (Tekijä), Yijun Bao (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: The autophagy pathway within the tumour microenvironment can be regulated to inhibit or promote tumour development. In the fight against tumour growth, immunotherapy induces an anti-tumour immune response, whereas autophagy modulates this immune response. A key protein in the autophagy p...